UA105459C2 - Композиция и способ получения энтерокиназы в дрожжах - Google Patents
Композиция и способ получения энтерокиназы в дрожжах Download PDFInfo
- Publication number
- UA105459C2 UA105459C2 UAA201307761A UAA201307761A UA105459C2 UA 105459 C2 UA105459 C2 UA 105459C2 UA A201307761 A UAA201307761 A UA A201307761A UA A201307761 A UAA201307761 A UA A201307761A UA 105459 C2 UA105459 C2 UA 105459C2
- Authority
- UA
- Ukraine
- Prior art keywords
- cell
- yeast
- enterokinase
- strain
- expression construct
- Prior art date
Links
- 108010013369 Enteropeptidase Proteins 0.000 title claims abstract description 135
- 102100029727 Enteropeptidase Human genes 0.000 title claims abstract description 134
- 240000004808 Saccharomyces cerevisiae Species 0.000 title claims abstract description 95
- 238000000034 method Methods 0.000 title claims abstract description 84
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 11
- 239000000203 mixture Substances 0.000 title description 10
- 230000014509 gene expression Effects 0.000 claims abstract description 151
- 108091033319 polynucleotide Proteins 0.000 claims abstract description 151
- 102000040430 polynucleotide Human genes 0.000 claims abstract description 151
- 239000002157 polynucleotide Substances 0.000 claims abstract description 151
- 210000005253 yeast cell Anatomy 0.000 claims abstract description 65
- 239000013604 expression vector Substances 0.000 claims abstract description 56
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 53
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 48
- 229920001184 polypeptide Polymers 0.000 claims abstract description 45
- 210000004027 cell Anatomy 0.000 claims description 92
- 238000003776 cleavage reaction Methods 0.000 claims description 43
- 230000007017 scission Effects 0.000 claims description 42
- 238000000746 purification Methods 0.000 claims description 11
- 150000007523 nucleic acids Chemical class 0.000 claims description 8
- 102000039446 nucleic acids Human genes 0.000 claims description 6
- 108020004707 nucleic acids Proteins 0.000 claims description 6
- IXKSXJFAGXLQOQ-XISFHERQSA-N WHWLQLKPGQPMY Chemical compound C([C@@H](C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)NC(=O)[C@@H](N)CC=1C2=CC=CC=C2NC=1)C1=CNC=N1 IXKSXJFAGXLQOQ-XISFHERQSA-N 0.000 claims description 3
- 238000000354 decomposition reaction Methods 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 description 44
- 125000003729 nucleotide group Chemical group 0.000 description 44
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 39
- 150000001413 amino acids Chemical group 0.000 description 31
- 108020004705 Codon Proteins 0.000 description 30
- 235000001014 amino acid Nutrition 0.000 description 28
- 230000000295 complement effect Effects 0.000 description 20
- 239000013598 vector Substances 0.000 description 16
- 239000002609 medium Substances 0.000 description 15
- 108091008146 restriction endonucleases Proteins 0.000 description 15
- 108090000623 proteins and genes Proteins 0.000 description 14
- 239000012634 fragment Substances 0.000 description 12
- 230000000694 effects Effects 0.000 description 11
- 230000001939 inductive effect Effects 0.000 description 11
- 229920001817 Agar Polymers 0.000 description 10
- 108020004414 DNA Proteins 0.000 description 10
- 239000008272 agar Substances 0.000 description 10
- 230000001404 mediated effect Effects 0.000 description 10
- 239000008188 pellet Substances 0.000 description 9
- 235000018102 proteins Nutrition 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 108010076504 Protein Sorting Signals Proteins 0.000 description 8
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 238000001262 western blot Methods 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 7
- 238000010367 cloning Methods 0.000 description 7
- 239000001963 growth medium Substances 0.000 description 7
- 230000006698 induction Effects 0.000 description 7
- 102100036826 Aldehyde oxidase Human genes 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 230000001413 cellular effect Effects 0.000 description 6
- 238000010561 standard procedure Methods 0.000 description 6
- 238000006467 substitution reaction Methods 0.000 description 6
- 235000006708 antioxidants Nutrition 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 238000010276 construction Methods 0.000 description 5
- 238000004520 electroporation Methods 0.000 description 5
- 239000013612 plasmid Substances 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- RCQMOSJJIVCPJO-UHFFFAOYSA-N 2-(5-methyl-2,4-dioxopyrimidin-1-yl)ethoxymethylphosphonic acid Chemical compound CC1=CN(CCOCP(O)(O)=O)C(=O)NC1=O RCQMOSJJIVCPJO-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- 102000053602 DNA Human genes 0.000 description 4
- 102000012410 DNA Ligases Human genes 0.000 description 4
- 108010061982 DNA Ligases Proteins 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 108091034117 Oligonucleotide Proteins 0.000 description 4
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 230000004913 activation Effects 0.000 description 4
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 4
- 229960000723 ampicillin Drugs 0.000 description 4
- 210000004899 c-terminal region Anatomy 0.000 description 4
- 238000004587 chromatography analysis Methods 0.000 description 4
- 239000003623 enhancer Substances 0.000 description 4
- 230000002255 enzymatic effect Effects 0.000 description 4
- 230000010354 integration Effects 0.000 description 4
- 239000012723 sample buffer Substances 0.000 description 4
- 238000001890 transfection Methods 0.000 description 4
- 230000009466 transformation Effects 0.000 description 4
- 229940035893 uracil Drugs 0.000 description 4
- 101710131969 Aldehyde oxidase 1 Proteins 0.000 description 3
- 230000006820 DNA synthesis Effects 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- 108700026244 Open Reading Frames Proteins 0.000 description 3
- 239000011324 bead Substances 0.000 description 3
- 230000003197 catalytic effect Effects 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000004737 colorimetric analysis Methods 0.000 description 3
- 230000009089 cytolysis Effects 0.000 description 3
- 210000000805 cytoplasm Anatomy 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 3
- 238000013507 mapping Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 210000003463 organelle Anatomy 0.000 description 3
- 229920002704 polyhistidine Polymers 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000035939 shock Effects 0.000 description 3
- 101150061183 AOX1 gene Proteins 0.000 description 2
- 229930024421 Adenine Natural products 0.000 description 2
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
- 101710194173 Alcohol oxidase 2 Proteins 0.000 description 2
- 108010062466 Enzyme Precursors Proteins 0.000 description 2
- 102000010911 Enzyme Precursors Human genes 0.000 description 2
- 108700028146 Genetic Enhancer Elements Proteins 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- 229920002873 Polyethylenimine Polymers 0.000 description 2
- 108010022999 Serine Proteases Proteins 0.000 description 2
- 102000012479 Serine Proteases Human genes 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 229960000643 adenine Drugs 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- -1 chymotrypsinogens Proteins 0.000 description 2
- 239000008121 dextrose Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 150000008300 phosphoramidites Chemical class 0.000 description 2
- 238000003752 polymerase chain reaction Methods 0.000 description 2
- 230000001323 posttranslational effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 230000004960 subcellular localization Effects 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 238000013519 translation Methods 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 101710149506 28 kDa protein Proteins 0.000 description 1
- KIUMMUBSPKGMOY-UHFFFAOYSA-N 3,3'-Dithiobis(6-nitrobenzoic acid) Chemical compound C1=C([N+]([O-])=O)C(C(=O)O)=CC(SSC=2C=C(C(=CC=2)[N+]([O-])=O)C(O)=O)=C1 KIUMMUBSPKGMOY-UHFFFAOYSA-N 0.000 description 1
- QFVHZQCOUORWEI-UHFFFAOYSA-N 4-[(4-anilino-5-sulfonaphthalen-1-yl)diazenyl]-5-hydroxynaphthalene-2,7-disulfonic acid Chemical compound C=12C(O)=CC(S(O)(=O)=O)=CC2=CC(S(O)(=O)=O)=CC=1N=NC(C1=CC=CC(=C11)S(O)(=O)=O)=CC=C1NC1=CC=CC=C1 QFVHZQCOUORWEI-UHFFFAOYSA-N 0.000 description 1
- 101800000112 Acidic peptide Proteins 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 238000009010 Bradford assay Methods 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 101710137943 Complement control protein C3 Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 102100034289 Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 Human genes 0.000 description 1
- 108010010256 Dietary Proteins Proteins 0.000 description 1
- 102000015781 Dietary Proteins Human genes 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 229920000209 Hexadimethrine bromide Polymers 0.000 description 1
- 101000634538 Homo sapiens Neuronal PAS domain-containing protein 1 Proteins 0.000 description 1
- 241000087799 Koma Species 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 241000406668 Loxodonta cyclotis Species 0.000 description 1
- 241001625930 Luria Species 0.000 description 1
- 101100237844 Mus musculus Mmp19 gene Proteins 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 102000007079 Peptide Fragments Human genes 0.000 description 1
- 108010039918 Polylysine Proteins 0.000 description 1
- 101800003414 Pro-elastase Proteins 0.000 description 1
- 108010040806 Prolipase Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 101150098533 SOST gene Proteins 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 101710152003 Suppressor of silencing P0 Proteins 0.000 description 1
- 101100152427 Taxus baccata TDC1 gene Proteins 0.000 description 1
- 108010027252 Trypsinogen Proteins 0.000 description 1
- 102000018690 Trypsinogen Human genes 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000005377 adsorption chromatography Methods 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 238000012870 ammonium sulfate precipitation Methods 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 238000010170 biological method Methods 0.000 description 1
- OHJMTUPIZMNBFR-UHFFFAOYSA-N biuret Chemical compound NC(=O)NC(N)=O OHJMTUPIZMNBFR-UHFFFAOYSA-N 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000012707 chemical precursor Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000021245 dietary protein Nutrition 0.000 description 1
- 230000002183 duodenal effect Effects 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 238000001641 gel filtration chromatography Methods 0.000 description 1
- 102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000001630 jejunum Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- KJLLKLRVCJAFRY-UHFFFAOYSA-N mebutizide Chemical compound ClC1=C(S(N)(=O)=O)C=C2S(=O)(=O)NC(C(C)C(C)CC)NC2=C1 KJLLKLRVCJAFRY-UHFFFAOYSA-N 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 210000000110 microvilli Anatomy 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 210000002824 peroxisome Anatomy 0.000 description 1
- 229940080469 phosphocellulose Drugs 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 229920000656 polylysine Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000004481 post-translational protein modification Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 230000009465 prokaryotic expression Effects 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 230000030788 protein refolding Effects 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 230000006337 proteolytic cleavage Effects 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 239000012898 sample dilution Substances 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000018448 secretion by cell Effects 0.000 description 1
- 230000009834 selective interaction Effects 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 238000001542 size-exclusion chromatography Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- 230000010474 transient expression Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 241001430294 unidentified retrovirus Species 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
- C12N1/18—Baker's yeast; Brewer's yeast
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Mycology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Botany (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Изобретение относится к изолированной полинуклеотидной молекулы, которая кодирует энтерокиназу, дрожжевому экспрессионному конструкту, который включает дрожжевой вектор экспрессии и полинуклеотидные молекулы, кодирующие энтерокиназу, к дрожжевой клетке, содержащей такой экспрессионный конструкт, способу продуцирования энтерокиназы с использованием таких дрожжевых клеток, и способу расщепления или получения рекомбинантного полипептида с использованием энтерокиназы, которая продуцируется с помощью таких способов.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41662210P | 2010-11-23 | 2010-11-23 | |
PCT/US2011/061334 WO2012071257A1 (en) | 2010-11-23 | 2011-11-18 | Compositions and methods of producing enterokinase in yeast |
Publications (1)
Publication Number | Publication Date |
---|---|
UA105459C2 true UA105459C2 (ru) | 2014-05-12 |
Family
ID=45034208
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA201307761A UA105459C2 (ru) | 2010-11-23 | 2011-11-18 | Композиция и способ получения энтерокиназы в дрожжах |
Country Status (20)
Country | Link |
---|---|
US (2) | US8557558B2 (ru) |
EP (1) | EP2643457B1 (ru) |
JP (1) | JP5425350B2 (ru) |
KR (1) | KR101920094B1 (ru) |
CN (1) | CN103282490B (ru) |
AU (1) | AU2011332131B2 (ru) |
BR (1) | BR112013012565A2 (ru) |
CA (1) | CA2816217C (ru) |
CL (1) | CL2013001476A1 (ru) |
DK (1) | DK2643457T3 (ru) |
ES (1) | ES2553149T3 (ru) |
HK (1) | HK1189028A1 (ru) |
IL (1) | IL226165A (ru) |
MX (1) | MX2013005749A (ru) |
MY (1) | MY170261A (ru) |
NZ (1) | NZ611164A (ru) |
RU (1) | RU2560577C2 (ru) |
SG (1) | SG190316A1 (ru) |
UA (1) | UA105459C2 (ru) |
WO (1) | WO2012071257A1 (ru) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SK500482016A3 (sk) | 2016-07-29 | 2018-02-05 | Univerzita Komenského v Bratislave | Expresná DNA kazeta nesúca gén kódujúci ľahký reťazec ľudskej enterokinázy, kmeň Pichia pastoris nesúci uvedenú expresnú DNA kazetu a spôsob jeho kultivácie |
RU2716975C1 (ru) * | 2019-01-09 | 2020-03-17 | Федеральное государственное бюджетное учреждение науки институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук (ИБХ РАН) | Рекомбинантная плазмидная днк, кодирующая гибридный белок l-hep, штамм escherichia coli продуцент указанного белка и способ получения рекомбинантного белка |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6746859B1 (en) | 1993-01-15 | 2004-06-08 | Genetics Institute, Llc | Cloning of enterokinase and method of use |
US7825233B2 (en) | 2004-06-30 | 2010-11-02 | Allergan, Inc. | Optimizing expression of active Botulinum Toxin type E |
US20110111483A1 (en) * | 2004-06-30 | 2011-05-12 | Allergan, Inc. | Optimizing Expression of Active Botulinum Toxin Type E |
JP2008508886A (ja) | 2004-08-04 | 2008-03-27 | アラーガン、インコーポレイテッド | 活性ボツリヌス毒素a型の発現の最適化 |
US20070281198A1 (en) | 2006-06-01 | 2007-12-06 | Lousenberg Robert D | Membranes electrode assemblies prepared from fluoropolymer dispersions |
US8013137B2 (en) | 2006-10-17 | 2011-09-06 | National University Corporation Hokkaido University | Modified enteropeptidase protein |
WO2008136014A1 (en) * | 2007-05-07 | 2008-11-13 | Usv Limited | Cloning and expression of enterokinase and its process for production |
CN102061302B (zh) * | 2010-11-26 | 2012-07-04 | 扬子江药业集团北京海燕药业有限公司 | 肠激酶轻链基因的合成及其表达产物的制备方法 |
-
2011
- 2011-11-18 SG SG2013037957A patent/SG190316A1/en unknown
- 2011-11-18 CA CA2816217A patent/CA2816217C/en active Active
- 2011-11-18 AU AU2011332131A patent/AU2011332131B2/en not_active Ceased
- 2011-11-18 EP EP11788004.7A patent/EP2643457B1/en active Active
- 2011-11-18 MY MYPI2013001797A patent/MY170261A/en unknown
- 2011-11-18 MX MX2013005749A patent/MX2013005749A/es active IP Right Grant
- 2011-11-18 RU RU2013128339/10A patent/RU2560577C2/ru active
- 2011-11-18 WO PCT/US2011/061334 patent/WO2012071257A1/en active Application Filing
- 2011-11-18 NZ NZ611164A patent/NZ611164A/en not_active IP Right Cessation
- 2011-11-18 BR BR112013012565A patent/BR112013012565A2/pt active Search and Examination
- 2011-11-18 JP JP2013540979A patent/JP5425350B2/ja not_active Expired - Fee Related
- 2011-11-18 CN CN201180062691.2A patent/CN103282490B/zh not_active Expired - Fee Related
- 2011-11-18 KR KR1020137016104A patent/KR101920094B1/ko active IP Right Grant
- 2011-11-18 ES ES11788004.7T patent/ES2553149T3/es active Active
- 2011-11-18 UA UAA201307761A patent/UA105459C2/ru unknown
- 2011-11-18 DK DK11788004.7T patent/DK2643457T3/en active
- 2011-11-23 US US13/303,691 patent/US8557558B2/en active Active
-
2013
- 2013-05-05 IL IL226165A patent/IL226165A/en active IP Right Grant
- 2013-05-23 CL CL2013001476A patent/CL2013001476A1/es unknown
- 2013-07-26 US US13/952,190 patent/US20130302853A1/en not_active Abandoned
-
2014
- 2014-02-25 HK HK14101776.2A patent/HK1189028A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2816217C (en) | 2014-07-29 |
DK2643457T3 (en) | 2015-11-30 |
CA2816217A1 (en) | 2012-05-31 |
ES2553149T3 (es) | 2015-12-04 |
US20130302853A1 (en) | 2013-11-14 |
EP2643457A1 (en) | 2013-10-02 |
KR20140018850A (ko) | 2014-02-13 |
CN103282490A (zh) | 2013-09-04 |
IL226165A0 (en) | 2013-06-27 |
JP5425350B2 (ja) | 2014-02-26 |
JP2014501511A (ja) | 2014-01-23 |
MY170261A (en) | 2019-07-13 |
AU2011332131A1 (en) | 2013-07-04 |
RU2560577C2 (ru) | 2015-08-20 |
HK1189028A1 (en) | 2014-05-23 |
WO2012071257A1 (en) | 2012-05-31 |
BR112013012565A2 (pt) | 2016-10-25 |
NZ611164A (en) | 2015-02-27 |
SG190316A1 (en) | 2013-06-28 |
CN103282490B (zh) | 2016-09-21 |
MX2013005749A (es) | 2013-08-01 |
US8557558B2 (en) | 2013-10-15 |
IL226165A (en) | 2017-02-28 |
RU2013128339A (ru) | 2014-12-27 |
AU2011332131B2 (en) | 2015-08-13 |
CL2013001476A1 (es) | 2014-01-31 |
KR101920094B1 (ko) | 2018-11-19 |
US20120156720A1 (en) | 2012-06-21 |
EP2643457B1 (en) | 2015-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20200181629A1 (en) | Yeast expressing a synthetic calvin cycle | |
Li et al. | Thioredoxin activity in the C terminus of Phalaris S protein | |
AU2012300885A1 (en) | Protein expression | |
EA014783B1 (ru) | Связывающий днк-сайт активатора транскрипции, пригодный для экспрессии генов | |
Sasaki et al. | Chloroplast envelope protein encoded by chloroplast genome | |
US11447780B2 (en) | Preparation of wheat cysteine protease triticain-alpha produced in soluble form and method of producing same | |
Shirabe et al. | Expression of human erythrocyte NADH-cytochrome b5 reductase as an α-thrombin-cleavable fused protein in Escherichia coli | |
UA105459C2 (ru) | Композиция и способ получения энтерокиназы в дрожжах | |
Kremp et al. | Non-AUG translation initiation generates peroxisomal isoforms of 6-phosphogluconate dehydrogenase in fungi | |
CN110819609B (zh) | 一种热稳定性提高的突变脂肪酶及其制备方法与应用 | |
RU2606014C1 (ru) | Рекомбинантная плазмидная ДНК pEFN877, детерминирующая экспрессию гибридного полипептида со свойствами 10-го домена фибронектина на поверхности клеток Escherichia coli, и штамм бактерий Escherichia coli BL21(DE3)pLysS/pEFN877 - продуцент гибридного полипептида со свойствами 10-го домена фибронектина на поверхности клеток | |
CN106459940B (zh) | 新型过氧化氢酶信号序列及利用其的过氧化氢酶表达方法 | |
KR100714116B1 (ko) | 췌장의 프로카복시펩티다제 b를 사용한 인슐린의 제조 | |
KR100798894B1 (ko) | 재조합단백질 생산용 단백질융합인자 | |
Leontovyc et al. | A Preliminary Characterization of a Novel Recombinant Clostridial Collagenase Blend. | |
Dong et al. | Nucleotide sequence analysis of a cDNA encoding chloroplastic fructose-1, 6-bisphosphatase from pea (Pisum sativum l.). | |
Yuzbasheva et al. | Protein display on the Yarrowia lipolytica yeast cell surface using the cell wall protein YlPir1 | |
WO2023057750A1 (en) | Chimeric protein and expression system | |
CN115820618A (zh) | Sc1-70抗原截短体、其制备方法和应用 | |
CN116926034A (zh) | 重组肌酸激酶同工酶及其制备方法和应用 | |
CN117777276A (zh) | 一种促进马克斯克鲁维酵母分泌表达人乳铁蛋白的方法 | |
KR20070027280A (ko) | 야로이아 속 효모에서의 세포 표면 단백질을 이용한목적단백질의 세포 표면 발현방법 | |
Hongsthong et al. | Effect of Temperature on the Desaturase Gene Translation in Spirulina Platensis Strain C1 | |
KINBARA et al. | 68 Proteolysis in Cell Functions VK Hopsu-Havu et al.(Eds.) IOS Press, 1997 |